Top compounds associated with response to C11orf65


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.02
mRNA KU-55933 CTRPv2 pan-cancer AAC -0.081 0.02
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.02
mRNA L-685458 CCLE pan-cancer AAC -0.1 0.03
mRNA CIL55A CTRPv2 pan-cancer AAC -0.11 0.03
mRNA Repligen 136 CTRPv2 pan-cancer AAC -0.081 0.03
mRNA Axitinib CTRPv2 pan-cancer AAC -0.074 0.03
mRNA CD-437 CTRPv2 pan-cancer AAC -0.07 0.03
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.03
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.08 0.03
Download CSV